Endocytic modulation of somatostatin receptors to reverse tumor resistance to peptide receptor radionuclide therapy

被引：0
|
作者：
Shmuel, Shayla [1 ]
Panikar, Sandeep Surendra [1 ]
Pereira, Patricia Ribeiro [1 ]
机构：
[1] WUSTL, St Louis, MO USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P344
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours
    Van Essen, Martijn
    Krenning, Eric P.
    De Jong, Marion
    Valkema, Roelf
    Kwekkeboom, Dik J.
    ACTA ONCOLOGICA, 2007, 46 (06) : 723 - 734
  • [2] Inter and intra-tumor somatostatin receptor 2 heterogeneity influences peptide receptor radionuclide therapy response
    Feijtel, Danny
    Doeswijk, Gabriela N.
    Verkaik, Nicole S.
    Haeck, Joost C.
    Chicco, Daniela
    Angotti, Carmelina
    Konijnenberg, Mark W.
    de Jong, Marion
    Nonnekens, Julie
    THERANOSTICS, 2021, 11 (02): : 491 - 505
  • [3] Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression
    Jahn, Ulrika
    Garske-Roman, Ulrike
    Sandstroem, Mattias
    Lubberink, Mark
    Sundin, Anders
    EJNMMI RESEARCH, 2023, 13 (01)
  • [4] Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression
    Ulrika Jahn
    Ulrike Garske-Román
    Mattias Sandström
    Mark Lubberink
    Anders Sundin
    EJNMMI Research, 13
  • [5] Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues
    Edgar J. Rolleman
    Marleen Melis
    Roelf Valkema
    Otto C. Boerman
    Eric P. Krenning
    Marion de Jong
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1018 - 1031
  • [6] Practical aspects of peptide receptor radionuclide therapy with somatostatin analogs in 2019
    Bournaud, C.
    Lombard-Bohas, C.
    Habouzit, V.
    Carlierd, T.
    Hindie, E.
    Ansquer, C.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2019, 43 (03): : 251 - 266
  • [7] Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy
    Krenning, EP
    de Jong, M
    Kooij, PPM
    Breeman, WAP
    Bakker, WH
    de Herder, WW
    van Eijck, CHJ
    Kwekkeboom, DJ
    Jamar, F
    Pauwels, S
    Valkema, R
    ANNALS OF ONCOLOGY, 1999, 10 : S23 - S29
  • [8] Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues
    Rolleman, Edgar J.
    Melis, Marleen
    Valkema, Roelf
    Boerman, Otto C.
    Krenning, Eric P.
    de Jong, Marion
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (05) : 1018 - 1031
  • [9] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues
    Bodei, L.
    Pepe, G.
    Paganelli, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2010, 14 (04) : 347 - 351
  • [10] Peptide receptor radionuclide therapy (PRRT) using somatostatin analogs.
    Capello, A
    Krenning, EP
    Bernard, HF
    Breeman, WA
    Van Den Aardweg, G
    De Jong, M
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 125P - 125P
12345